DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
Herein, we describe the design, synthesis, and biological evaluation of 15 Contilisant+Tubastatin A hybrids. These ligands are polyfunctionalized indole derivatives developed by juxtaposing selected pharmacophoric moieties of Contilisant and Tubastatin A to act as multifunctional ligands. Compounds 3 and 4 were identified as potent HDAC6 inhibitors (IC = 0.012 μM and 0.035 μM, respectively), so they were further evaluated in Drosophila and human cell models of Parkinson’s disease (PD). Both compounds attenuated PD-like phenotypes, such as motor defects, oxidative stress, and mitochondrial dysfunction in PD model flies. Ligands 3 and 4 were also studied in the transgenic Caenorhabditis elegans CL2006 model of Alzheimer’s disease (AD). Both compounds were nontoxic, did not induce undesirable animal functional changes, inhibited age-related paralysis, and improved cognition in the thrashing assay. These results highlight 3 and 4 as novel multifunctional ligands that improve the features of PD and AD hallmarks in the respective animal models., JMC thanks AEI (Government of Spain; Grant PID2019-105813RB-C21) and UCJC
[Grant: “In vivo analysis of new analogues of Contilisant (MITOPI) (2022)”] for support.
This work is part of the MINA-CM program (number S2022/BMD-7236), funded by the
call for the implementation of programs of R&D activities between research groups of
the Community of Madrid in Biomedicine 2022 (Order 1171/2022). MTP thanks MINA-
CM program (number S2022/BMD-7236) for a contract. MMRF and AP thank
Comunidad de Madrid for a “Investigo” Contract (2022-23). II thanks AEI (Government
of Spain; Grant PID2019-105813RB-C22) for support. AS thanks the UAEU for financial
support by Strategic Research Program-Zayed Center for Health Sciences (Grant #
G00003680) and by the SURE PLUS (grant #: G00003976) (2022). CGF thanks AEI
(MINECO-FEDER, Government of Spain; Grant PID2022-139016OA-I00), Generalitat
de Catalunya (Grant 2021 SGR 00357), and AGAUR (Grant 2023Llavor005). ABS
acknowledges the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) for
her FI-SDUR fellowship (2021FISDU 00182). Some strains were provided by the CGC,
which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
DK and SG thank the Slovenian Research and Innovation Agency (Research Core
Funding grant P1-0208, and project J1-3018) for finnancial support. LSH wants to
greatfully acknowledge experimental support by Philipp Stegen.
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-105813RB-C21
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-105813RB-C22
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-139016OA-I00